Gotham Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Gotham Asset Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-19,122	Closed	-$1.12M	–	1261
2019 Q2	$1.12M	Buy	+19,122	New	+$988K	0.02%	609
2018 Q2	–	Sell	-5,406	Closed	-$214K	–	1097
2018 Q1	$214K	Buy	+5,406	New	+$210K	﹤0.01%	880
2017 Q2	–	Sell	-3,780	Closed	-$55K	–	1125
2017 Q1	$55K	Buy	+3,780	New	+$56K	﹤0.01%	963

Other funds holding ARNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Gotham Asset Management's ARNA Position: Q3 2019 in Review

Gotham Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2019, closing a stake of 19,122 shares — an estimated $1.12M sold.

Gotham Asset Management first reported a position in ARNA in Q1 2017 and held it in 3 quarters. The position peaked at $1.12M in Q2 2019. 230 funds tracked by Wall St. Rank hold ARNA as of Q3 2019.

Gotham Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
Gotham Asset Management sold 19,122 Arena Pharmaceuticals Inc shares in Q3 2019, an estimated $1.12M.
Gotham Asset Management first reported a position in Arena Pharmaceuticals Inc in Q1 2017 and held it in 3 quarters.
Gotham Asset Management's Arena Pharmaceuticals Inc position peaked at $1.12M in Q2 2019.
230 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2019.

Based on Gotham Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.